Suchergebnisse - "Langer, Jakob"

PubPharm (101)

41

Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”

enthalten in: Diabetes therapy | 2020

von Brooks, A. | Langer, J. | Tervonen, T. | +3

42

Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation

enthalten in: Journal of lipid research | 2020

von Lundsgaard, A. | Fritzen, A. | Nicolaisen, T. | +12

43

Protein Spin Labeling with a Photocaged Nitroxide Using Diels-Alder Chemistry

enthalten in: Chembiochem : a European journal of chemical biology | 2019

von Kugele, A. | Silkenath, B. | Langer, J. | +2

44

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal-Bolus Therapy

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2019

von Langer, J. | Wolden, M. | Shimoda, S. | +2

45

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy

enthalten in: Diabetes therapy | 2019

von Langer, J. | Wolden, M. | Shimoda, S. | +2

46

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy

enthalten in: Diabetes therapy | 2019

von Langer, J. | Wolden, M. | Shimoda, S. | +2

47

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy

enthalten in: Diabetes therapy | 2019

von Langer, J. | Wolden, M. | Shimoda, S. | +2

48

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan : A Discrete Choice Experiment

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2019

von Brooks, A. | Langer, J. | Tervonen, T. | +3

49

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

enthalten in: Diabetes therapy | 2019

von Brooks, A. | Langer, J. | Tervonen, T. | +3

50

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

enthalten in: Diabetes therapy | 2019

von Brooks, A. | Langer, J. | Tervonen, T. | +3